Dr. Farnaes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Cambridge Parkway
Suite 800E
Cambridge, MA 02142
Summary
- Dr. Lauge Farnaes is board certified in pediatric hematology, oncology and pediatric infectious disease. Currently he is Senior director of explorations at Pioneering medicines a division of Flagship Pioneering developing new therapies to tackle diseases.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Pediatric Infectious Diseases, 2015 - 2018
- University of California (San Diego) Medical CenterFellowship, Pediatric Hematology/Oncology, 2014 - 2018
- University of California (San Diego) Medical CenterResidency, Pediatrics, 2011 - 2014
- University of California San Diego School of MedicineClass of 2011
- University of California, San DiegoPhD, Oceanography - Marine/Organic Chemistry, 2006 - 2009
- University of California, San DiegoMSc, Biology, 1999 - 2000
- University of California, San DiegoBA, Anthropology, 1995 - 1999
- University of California, San DiegoBS, Biochemistry, 1995 - 1999
Certifications & Licensure
- CA State Medical License 2013 - 2027
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Roderick K. Calverly Humanitarian Service Award 2011
- Gold Humanism in Medicine 2010
Publications & Presentations
PubMed
- 133 citationsProject Baby Bear: Rapid precision care incorporating rWGS in 5 California children's hospitals demonstrates improved clinical outcomes and reduced costs of care.David Dimmock, Sara A. Caylor, Bryce Waldman, Wendy Benson, Christina Ashburner
American Journal of Human Genetics. 2021-07-01 - 350 citationsMeta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseasesMichelle M. Clark, Zornitza Stark, Lauge Farnaes, Tiong Yang Tan, Susan M. White
NPJ Genomic Medicine. 2018-07-09 - 292 citationsRapid whole-genome sequencing decreases infant morbidity and cost of hospitalization.Lauge Farnaes, Amber Hildreth, Nathaly M. Sweeney, Michelle M. Clark, Shimul Chowdhury
NPJ Genomic Medicine. 2018-04-04
Journal Articles
- Napyradiomycin Derivatives, Produced by a Marine-Derived Actinomycete, Illustrate Cytotoxicity by Induction of ApoptosisLauge Farnaes, Nicole G Coufal, Christopher A Kauffman, Arnold L Rheingold, Antonio G Dipasquale, Paul R Jensen, William Fenical, Journal of Natural Products, 1/1/2013
- Napyradiomycins CNQ525510B and A80915C Target the Hsp90 Paralogue Grp94Lauge Farnaes, James J La Clair, William Fenical, Organic & Biomolecular Chemistry, 1/1/2013
- Bactericidal Kinetics of Marine-derived Napyradiomycins against Contemporary Methicillin-resistant Staphylococcus AureusNina M Haste, Lauge Farnaes, Varahenage R Perera, William Fenical, Victor Nizet, Mary E Hensler, Marine Drugs, 1/1/2011
- Join now to see all
Books/Book Chapters
Other
- Novel Analogs and a Protein Target for the Napyradiomycins, PhD ThesisUniversity of California, San Diego
1/1/2009 - Antibodies to Annexin XI, Isolated from a Pateint with Felty's Syndrome, Show That Annexin XI Co-localizes with Tubulin and Euchromatin, MS ThesisUniversity of California, San Diego
1/1/2000
Press Mentions
- State-Funded Genome Sequencing Pilot Improves Outcomes, Saves Costs in Critically Ill NewbornsJune 18th, 2020
- San Diego Institutes Launch Coronavirus Testing, Research InitiativeJune 16th, 2020
- San Diego's Scientific and Medical Institutes Collaborate on Large-Scale Research Program to Study Spread of COVID-19June 16th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: